A Phase 1, Single-centre, Double-blind, Randomized, Placebo-controlled, Two-cohort, Two-period Crossover Study of the Hemodynamic Interactions Between Avanafil and Two alpha-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-aged Healthy Male Subjects.

Trial Profile

A Phase 1, Single-centre, Double-blind, Randomized, Placebo-controlled, Two-cohort, Two-period Crossover Study of the Hemodynamic Interactions Between Avanafil and Two alpha-Adrenergic Blockers, Doxazosin and Tamsulosin, in Middle-aged Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jan 2011

At a glance

  • Drugs Avanafil; Doxazosin; Tamsulosin
  • Indications Benign prostatic hyperplasia; Erectile dysfunction; Hypertension
  • Focus Pharmacodynamics
  • Sponsors VIVUS
  • Most Recent Events

    • 06 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top